
Hims & Hers launches five new compounded peptides for longevity amid FDA approval gaps and safety debates
Hims & Hers Health has introduced five new compounded peptide and longevity treatments in the U.S. through its Peptides+ platform, including sermorelin, glutathione, NAD+, vitamin B-12, and L-carnitine. These products are not FDA-approved but are leg...


